Linfu Chen
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoplatforms for cancer theranostics 15
-
- Gut microbiota and health 6
- Co-authors
- Zhuang Liu (18 shared papers)Qian Chen (26 shared papers)Yang Yang (19 shared papers)Maoyi Li (8 shared papers)Wenjun Zhu (2 shared papers)Qiufang Chen (2 shared papers)Jun Zhou (1 shared paper)Xinjie Li (1 shared paper)
In The Last Decade
Linfu Chen
37 papers receiving 1.7k citations
Linfu Chen's Hit Papers
Peers
Comparison fields: 5 of 111
- Biomaterials 262
- Pharmaceutical Science 113
- Biotechnology 158
- Rehabilitation 93
- Biomedical Engineering 649
Countries citing papers authored by Linfu Chen
This map shows the geographic impact of Linfu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linfu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linfu Chen more than expected).
Fields of papers citing papers by Linfu Chen
This network shows the impact of papers produced by Linfu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linfu Chen. The network helps show where Linfu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Linfu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery Hit paper breakdown → | 2022 | 501 |
| 2 | 2021 | 106 | |
| 3 | 2022 | 103 | |
| 4 | Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response Hit paper breakdown → | 2024 | 89 |
| 5 | 2023 | 82 | |
| 6 | 2021 | 75 | |
| 7 | 2023 | 74 | |
| 8 | 2022 | 63 | |
| 9 | 2023 | 59 | |
| 10 | 2024 | 51 | |
| 11 | 2022 | 50 | |
| 12 | 2024 | 45 | |
| 13 | 2023 | 45 | |
| 14 | 2021 | 43 | |
| 15 | 2023 | 40 | |
| 16 | 2023 | 36 | |
| 17 | 2024 | 34 | |
| 18 | 2022 | 26 | |
| 19 | 2024 | 26 | |
| 20 | 2023 | 23 |
About Linfu Chen
Linfu Chen is a scholar working on Biomedical Engineering, Molecular Biology, Immunology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Cancer Research and Treatments (10 papers), Inhalation and Respiratory Drug Delivery (7 papers), Immunotherapy and Immune Responses (7 papers), Gut microbiota and health (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Biomaterials (262 citations), Pharmaceutical Science (113 citations), Biotechnology (158 citations), Rehabilitation (93 citations) and Biomedical Engineering (649 citations). Linfu Chen has collaborated with scholars based in China, Australia and Macao. Frequent co-authors include Zhuang Liu, Qian Chen, Yang Yang, Maoyi Li, Wenjun Zhu, Qiufang Chen, Jun Zhou, Xinjie Li, Ziliang Dong and Jingjing Shen. Their work appears in journals such as Advanced Materials, ACS Nano, Science Advances, Advanced Functional Materials and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.